Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
People with cancer, heart disease and diabetes are at increased risk for serious illness from COVID-19.
Non-alcoholic fatty liver disease is more common among those with the virus compared with the general population.
This finding, which is in keeping with initial studies out of China and Italy, is preliminary as the CDC continues to gather data.
Without swift unprecedented action, more than 2 million Americans could die.
Lower rates of targeted interventions and care strategies for acute heart problems compared with HIV-negative people are a likely factor.
The 2019 Liver Meeting in Boston provided an array of important findings about the treatment and prevention of chronic liver diseases.
However, a recent study found that this varied based on the specific integrase inhibitor used.
The virus is as strongly associated with irregular heartbeat as with high blood pressure.
Alexa can now securely transmit and receive personalized medical information.
HIV is associated with an elevated risk of diabetes.
HIV-positive individuals tend to develop frailty at a younger age than the general population.
This from a small study of people who switched from a boosted protease inhibitor to Isentress (raltegravir) or Tivicay (dolutegravir).
Non-alcoholic fatty liver disease can lead to more severe, potentially fatal liver diseases, including cirrhosis.
However, while HbA1c and fasting glucose levels decline after a hep C cure, the clinical significance of such shifts remains unclear.
A research team has sought to address the critical lack of treatment guidelines for addressing HIV’s complex effects on aging.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.